Home » Sanofi’s Patents on Cancer Drug Taxotere Invalidated
Sanofi’s Patents on Cancer Drug Taxotere Invalidated
Sanofi’s two patents on the cancer drug Taxotere were ruled invalid and unenforceable by a U.S. court today in a victory for generic-drug makers Hospira and Apotex.
Bloomberg
Bloomberg
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May